Immune Therapeutics Inc Stock - IMUN Share Price Today, News and Discussion

Immune Therapeutics, Inc. is a biopharmaceutical company focused on the licensing and development of prescription medications for humans in Africa, Central and South America, the Caribbean and China. The company was founded by Noreen Griffin on December 2, 1993 and is headquartered in Winter Park, FL.

Sector:

Health Technology

Industry:

Pharmaceuticals Major

Employees:

N/A

Current Price	$0.50
Prev Close	$0.3706
Open	$0.50
Dividend Yield	0.00%
50-Day Moving Average	$0.7442
Beta	0.30
Avg. Volume	539.45
PE Ratio	N/A

52-Week High	$2.85
52-Week Low	$0.3701
Market Capitalization	$41.52M
EPS	-$5.52
Price to Book	-15.79
Revenue Per Employee	N/A
Enterprise Value/EBITDA	-82.68

No IMUN news at the moment.

IMUN Immune Therapeutics Inc

About

Feed

Fundamentals

News